(Q74186209)

English

Diagnosis related group costs in a regulated environment. A note about their economic interpretation

scientific article published on 01 February 2000

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10947335

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947335%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

title

Diagnosis related group costs in a regulated environment. A note about their economic interpretation (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10947335

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947335%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

author name string

C Le Pen

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10947335

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947335%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

G Berdeaux

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10947335

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947335%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

publication date

1 February 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10947335

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947335%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

10947335

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947335%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

volume

17

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10947335

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947335%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10947335

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947335%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

page(s)

115-120

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10947335

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947335%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

exact match

https://scigraph.springernature.com/pub.10.2165/00019053-200017020-00001

0 references

cites work

A cost-utility analysis of second-line chemotherapy in metastatic breast cancer. Docetaxel versus paclitaxel versus vinorelbine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10947335

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10947335

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(Q74186209)

Diagnosis related group costs in a regulated environment. A note about their economic interpretation

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)